Valois vaccinates without needles

Published: 1-Jan-2004
Regulatory


Valois, of France, a member of the Aptar Group, has launched the Dolphin Unitdose to enable flu vaccinations to be given by the nasal and pulmonary routes.

Compared with injection, the Dolphin Unitdose is said to offer a number of advantages: no risk of injury; precise optimum dosage; pain-free administration; ease of use; can be used in any position.

In addition to flu vaccine, the nasal spray will be used for other vaccines, enabling prevention of ear, nose and throat conditions such as bronchiolitis and ear infections. The company also foresees its use in biodefence programmes to combat smallpox, anthrax, ricin, etc.

The global vaccination market is growing at an annual rate of 10.5% with 94 million doses expected to be administered in the US alone in 2003.

  • Companies:
  • Aptar Beauty
See more

You may also like

Training & Education

Webinar hosted by Aptar Pharma

Read more
Aptar Pharma, a leading provider of innovative drug delivery systems, announced it will host a live, complimentary webinar titled “Optimizing Patient Adherence and Compliance in Eye Care” on 21 November 21 at 11 AM EST

Trending Articles

  1. Asahi Kasei Pharma grows its global portfolio with anti-CX3CR1 license The licensing deal with Chiome enhances its open innovation platform
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  4. Are you ready for EP compliance for handheld Raman spectrometers? Thermo Fisher Scientific has adjusted all validation procedures and acceptance criteria for initial instrument calibration as well as annual calibration re-certifications
  5. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Training & Education

Webinar hosted by Aptar Pharma

Aptar Pharma, a leading provider of innovative drug delivery systems, announced it will host a live, complimentary webinar titled “Optimizing Patient Adherence and Compliance in Eye Care” on 21 November 21 at 11 AM EST
Packaging

Real-time medication management technology

Aptar Pharma and Kali Care develop technology to address the challenge of monitoring adherence in ophthalmic clinical trial
Regulatory

Next Breath certified as Centre for Pharmaceutical Equivalence in Brazil

Authorised to perform in vitro testing for generic pulmonary and nasal drug products and devices in the country
Regulatory

Accelerating and enhancing toxicology assessments

Infographic guides users through ToxHQ’s speedy assessment features
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535

Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
Regulatory

Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy

The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain

With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
Subscribe now